Elagolix Sodium
- Introduction
- newest products
Introduction
Elagolix Sodium
Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is over 170 million women worldwide.
newest products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione (1150560-54-5) |
CAS: 1150560-54-5; Elagolix Sodium; Elagolix Sodium intermediate
|
|
In Stock
|
|
|
|
|
5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione (830346-48-0) |
CAS: 830346-48-0; Elagolix Sodium; Elagolix Sodium intermediate
|
|
In Stock
|
|
|
|
|
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidin (1150560-59-0) |
CAS: 1150560-59-0; Elagolix Sodium; Elagolix Sodium intermediate
|
|
In Stock
|
|
|
|
|
Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- (830346-47-9) |
CAS: 830346-47-9; Elagolix Sodium; Elagolix Sodium intermediate
|
|
In Stock
|
|
|
|
|
Elagolix Sodium (832720-36-2) |
CAS: 832720-36-2; Elagolix Sodium manufacturer; Elagolix Sodium API; Endometriosis
|
|
In Stock
|
|
|
|
|
2-fluoro-3-methoxyphenylboronic acid (352303-67-4) |
CAS: 352303-67-4; Elagolix Sodium; Elagolix Sodium intermediate
|
|
In Stock
|
|
